BPC-157 — Compound Overview
A researcher-focused overview of BPC-157: what the compound is, its chemistry, how it appears in the published literature, and how Index Peptides documents each batch.
What is BPC-157?
BPC-157 (Body Protection Compound 157) is a synthetic peptide made of 15 amino acids. Its sequence is a partial fragment of a larger protective protein originally identified in human gastric juice. The material itself is produced by solid-phase peptide synthesis and supplied as a lyophilised powder.
BPC-157 is classified as a research chemical. It is not an ingredient in any approved medicine and has not been evaluated by the MHRA, EMA, or FDA.
Chemistry and structure
BPC-157 is a linear pentadecapeptide with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (GEPPPGKPADDAGLV), CAS registry number 137525-51-0, molecular formula C62H98N16O22 and a monoisotopic mass of approximately 1419.6 g/mol for the free acid. Commercial material is commonly supplied as an acetate salt; the certificate of analysis for each batch records the form tested.
BPC-157 in the research literature
BPC-157 appears widely in preclinical literature — primarily rodent and in-vitro studies — including work on gastrointestinal tissue models, tendon and ligament fibroblast cultures, and signalling pathways involved in angiogenesis. The compound's literature is almost entirely preclinical: controlled human data are lacking, and no conclusions about effects in humans can be drawn from it.
Researchers reviewing this literature should note that study methodologies, doses, models and routes vary substantially between papers, which is one reason batch-level identity and purity documentation matters for reproducibility.
Regulatory status
BPC-157 is not an approved medicine in any jurisdiction and is prohibited in sport by the World Anti-Doping Agency (WADA) under section S0 (unapproved substances). Index Peptides supplies BPC-157 strictly for in-vitro laboratory research. It is not for human or veterinary use of any kind.
Form, handling and storage
BPC-157 is supplied as a lyophilised (freeze-dried) powder in a sealed vial. Lyophilised peptides are best stored at -20°C, desiccated and protected from light; long-term stability data are batch-specific and recorded against the batch record. Handling is the responsibility of the qualified researcher.
Batch documentation at Index Peptides
Every released batch of BPC-157 is HPLC purity tested and LC-MS identity confirmed (expected versus detected mass), with the certificate of analysis published on the product page and verifiable by lot number through the batch lookup tool.
Frequently asked questions
Is BPC-157 approved for human use?
No. BPC-157 is not an approved medicine anywhere in the world. Index Peptides supplies it strictly for in-vitro laboratory research — not for human or animal consumption, administration, or any in-vivo use.
What formats does Index Peptides supply?
BPC-157 is listed as 5mg and 10mg single-compound vials, and as part of multi-peptide blend vials. Every format carries the same batch documentation requirements.
How is each batch verified?
By reversed-phase HPLC for purity and LC-MS for identity (expected vs detected mass). The certificate of analysis is published on the product page, and any batch can be checked by its lot number on the verify page.
How should BPC-157 be stored?
As supplied (lyophilised), store at -20°C, desiccated and protected from light, per the batch record.
References
Research use only. Not for human or animal consumption.